Affiliation:
1. National Institute of Technology Warangal
2. CSIR-National Chemical Laboratory
3. Birla Institute of Technology and Science-Pilani
Abstract
Abstract
A simple and effective three-component one-pot green methodology was employed for the synthesis of a new thiazolidine-2,4-dione based bisspirooxindolo-pyrrolidine derivatives using [Bmim]BF4 ionic liquid via [3 + 2] cycloaddition reaction. It is an environmentally benign, column chromatography-free, shorter reaction time, good yield and easy product isolation method. The synthesized compounds 10a-x, were thoroughly characterized by using various spectroscopic methods like FT-IR, 1H NMR, 13C NMR, Mass spectrometry and finally by single crystal X-ray diffraction method. In vitro anti-tubercular (anti-TB) activity studies were carried out on these synthesized compounds, and they showed good to moderate anti-TB activity against Mycobacterium tuberculosis H37Rv strain. The compound 10a exhibited good anti-TB activity, with an MIC (Minimum Inhibitory Concentration) value of 12.5 µg/mL, and the compounds 10m, 10o and 10r showed moderate activity with an MIC value of 25.0 µg/mL. Remaining compounds exhibited poor activity against Mycobacterium tuberculosis. Ethambutol, rifampicin and isoniazid were used as standard drugs. Furthermore, in silico molecular docking experiments on the TB protein (PDB ID: 1DF7) were carried out to understand the binding interactions, and they showed least binding energy values ranging from − 8.9 to -7.2 kcal/mol.
Publisher
Research Square Platform LLC
Reference61 articles.
1. Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme;Venugopala KN;J Enzyme Inhib Med Chem,2021
2. Ionic liquid-promoted one-pot synthesis of thiazole-imidazo[2,1-b] [1,3,4]thiadiazole hybrids and their anti-tubercular activity;Ramprasad J;Medchemcomm,2016
3. 4 tuberculosis chemotherapy: recent developments and future perspectives;Bhowruth V;Prog Med Chem,2007
4. Novel insights into the pharmacometabonomics of first-line tuberculosis drugs relating to metabolism, mechanism of action and drug-resistance;Preez ID;Drug Metab Rev,2018
5. Anti-tuberculosis drug induced hepatotoxicity and associated factors among tuberculosis patients at selected hospitals, ethiopia;Molla Y;Hepatic Med Evid Res,2021